Preemptive therapy in immunocompromised hosts.
暂无分享,去创建一个
[1] J. Niland,et al. A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants , 1991 .
[2] G. Gerna,et al. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins , 1990, Journal of clinical microbiology.
[3] K. Sullivan,et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.
[4] R. Rubin,et al. Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice , 1989, Antimicrobial Agents and Chemotherapy.
[5] W. V. van Son,et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood , 1988, Journal of clinical microbiology.
[6] E. Reed,et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. , 1988, Annals of internal medicine.
[7] D. Stover,et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. , 1988, Annals of internal medicine.
[8] M. Thornquist,et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. , 1988, The New England journal of medicine.
[9] R. Gale,et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. , 1987, Annals of internal medicine.
[10] N. Flournoy,et al. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. , 1982, Reviews of infectious diseases.